Drug repurposing has the potential to deliver new therapies faster and at a fraction of the cost of traditional drug development. However, identifying meaningful opportunities remains difficult, with valuable signals often hidden across thousands of research publications.
MadeAi combines AI-powered literature review with expert human validation to accelerate evidence synthesis while maintaining transparency, accuracy, and regulatory-grade quality.
Download How AI is Transforming Literature Reviews into Drug Repurposing Opportunities to see how MadeAi analyzed 2,140 publications in 84 hours and uncovered promising therapeutic signals across multiple disease areas.
